Mark S. Aloia, Ph.D.

Mark S. Aloia, Ph.D. Associate Professor, National Jewish Health Vice President and Global Lead, Behavior Change, Royal Philips Mark Aloia is Associate Professor of Medicine at National Jewish Health in Denver, CO. He has also been on the faculty at the University of Rochester and at Brown University as a prominent sleep researcher. Dr. Aloia has studied the neuropsychology of sleep and adherence to Positive Airway Pressure therapy for the past 25 years. His focus on behavioral methods to improve adherence to treatment has made significant contributions to the sleep and health psychology fields. Dr. Aloia has received over $15M in NIH funding to date. He serves as an NIH grant reviewer and has published over 50 scientific papers in high quality journals. Dr. Aloia is also on the Editorial Boards of the journals Sleep, Health Psychology, and Behavioral Sleep Medicine and has edited a book with two colleagues entitled, Behavioral Treatments for Sleep Disorders. His role with Philips began overseeing the research efforts of the sleep and respiratory business. He and his research team at Philips have conducted over 100 clinical trials including regulatory trials, post-market studies, preference trials, and trials with academic partners. He has faced the challenge of conducting highly scientific clinical trials within the rapidly changing and time-constrained business environment, and has begun to demonstrate the benefits of this combined effort by helping build psychology into products that can result in improved patient outcomes. His new role involves bringing the psychology of behavior change to the products and services offered by the Company.